Efficient in vivo protection of nigral dopaminergic neurons by lentiviral gene transfer of a modified Neurturin construct
- 30 September 2005
- journal article
- research article
- Published by Elsevier in Experimental Neurology
- Vol. 195 (1) , 49-60
- https://doi.org/10.1016/j.expneurol.2005.03.006
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- In vivo gene delivery of glial cell line-derived neurotrophic factor for Parkinson's diseaseAnnals of Neurology, 2003
- Neuroprotection in the rat Parkinson model by intrastriatal GDNF gene transfer using a lentiviral vectorNeuroReport, 2002
- Glial Cell Line-Derived Neurotrophic Factor (GDNF) Gene Delivery Protects Dopaminergic Terminals from DegenerationExperimental Neurology, 2001
- Lentiviral Vectors as a Gene Delivery System in the Mouse Midbrain: Cellular and Behavioral Improvements in a 6-OHDA Model of Parkinson's Disease Using GDNFExperimental Neurology, 2000
- The GDNF family ligands and receptors — implications for neural developmentCurrent Opinion in Neurobiology, 2000
- In Vivo Protection of Nigral Dopamine Neurons by Lentiviral Gene Transfer of the Novel GDNF-Family Member Neublastin/ArteminMolecular and Cellular Neuroscience, 2000
- Characterization of Behavioral and Neurodegenerative Changes Following Partial Lesions of the Nigrostriatal Dopamine System Induced by Intrastriatal 6-Hydroxydopamine in the RatExperimental Neurology, 1998
- Multiply attenuated lentiviral vector achieves efficient gene delivery in vivoNature Biotechnology, 1997
- Region-specific differentiation of the hippocampal stem cell line HiB5 upon implantation into the developing mammalian brainCell, 1991
- Requirement for Activin a and Transforming Growth Factor--β1 Pro-Regions in Homodimer AssemblyScience, 1990